Stem cell transplantation for Crohn's disease
1Wolfson Digestive Diseases Centre, University Hospital, Nottingham NG7 2UH, UK. cj.hawkey@nottingham.ac.uk
Insights
Hematopoietic stem cell transplantation shows promise for treating Crohn's disease, potentially offering significant improvements or even cures. Genetic factors and non-immune mechanisms may influence treatment outcomes.
Area of Science:
- Immunology
- Gastroenterology
- Regenerative Medicine
Background:
- Inflammatory bowel disease (IBD), particularly Crohn's disease, is a significant health concern.
- Current treatments for Crohn's disease have limitations, driving the search for novel therapeutic approaches.
Purpose of the Study:
- To explore the potential benefits of hematopoietic stem cell transplantation (HSCT) for patients with Crohn's disease.
- To investigate the role of genetic factors and non-immune mechanisms in HSCT outcomes for IBD.
Main Methods:
- Review of case reports detailing HSCT in Crohn's disease patients.
- Analysis of a case involving NOD2 mutation transmission via allogeneic transplant.
- Observation of donor phenotype in lamina propria myofibroblasts.
Main Results:
- Case reports suggest HSCT can lead to major improvements, with potential for remission in some Crohn's disease patients.
- The development of Crohn's disease post-transplant highlights the influence of immune system genotype (e.g., NOD2 mutation).
- Donor-derived myofibroblasts indicate that non-immune mechanisms contribute to therapeutic effects.
Conclusions:
- Hematopoietic stem cell transplantation is a promising therapeutic avenue for Crohn's disease.
- Both immune and non-immune factors, including genetic predisposition, play a role in the efficacy of HSCT for IBD.
- A clinical trial is underway to further evaluate the value of HSCT in Crohn's disease treatment.
Abstract:
There is much interest in the possibility that haematopoietic stem cell transplantation might benefit patients with inflammatory bowel disease, with an emphasis on Crohn's disease. Case reports of patients with Crohn's disease undergoing stem cell transplantation for other reasons, or specifically for Crohn's disease, support the view that major improvements can be achieved, with even the possibility of a cure in a small number of, but certainly not all, cases. The development of Crohn's disease in a previously normal patient receiving an allogeneic transplant from an individual with the NOD2 mutation illustrates the importance of the genotype of the immune system. Population of the lamina propria by myofibroblasts with the donor's phenotype shows that non-immune mechanisms make also play a part. A clinical trial to determine the value of stem cell transplantation in Crohn's disease has been set up under the supervision of the European Group for Blood and Marrow Transplantation.
More Related Videos
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
11:24Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
Published on: October 18, 2011
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:22Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...